Financials

  • Market Capitalization 277.94 M
  • Employee 48
  • Founded 2015
  • CEO N/A
  • Website www.alxoncology.com
  • Headquarter Delaware, United States
  • FIGI BBG00VR8SDG8
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.59
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3393
TRDA
Entrada Therapeutics, Inc. - Common Stock
7.01 USD-3.58%-7.40%+21.28%+0.57%272.95 M USD
3402
AVXL
Anavex Life Sciences Corp. - Common Stock
3.00 USD-4.15%-8.26%+17.19%-67.39%278.02 M USD
3407
ZNTL
Zentalis Pharmaceuticals, Inc. - common stock
3.73 USD-3.87%-3.37%-18.91%+108.38%267.34 M USD
3416
GLSI
Greenwich LifeSciences, Inc. - Common stock
18.73 USD+2.74%+11.36%+37.82%+62.02%274.92 M USD

Notizie